446 results match your criteria: "Meningioma Optic Nerve Sheath"

Article Synopsis
  • - Optic nerve sheath meningiomas are rare tumors that can lead to vision loss, making accurate diagnosis challenging, especially since confirming their presence often requires risky procedures.
  • - Current diagnostic methods primarily include CT and MRI, but these imaging techniques may not always yield a clear diagnosis, prompting the need for other alternatives.
  • - This case study highlights the successful use of a [99mTc]Tc-Tektrotyd SPECT/CT scan as a non-invasive method for diagnosing orbital tumors, leveraging the radiopharmaceutical's ability to bind to somatostatin receptor subtype 2 found in meningiomas.
View Article and Find Full Text PDF

Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma.

Neurooncol Adv

September 2024

Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.

Article Synopsis
  • Primary optic nerve sheath meningiomas (ONSMs) are benign tumors that can cause gradual vision loss, and radiation therapy, particularly proton therapy, is key for treatment as it may improve visual function while minimizing side effects.* -
  • In a study of 32 patients treated with proton beam radiotherapy, results showed a 100% local control rate after 5 years and 84.4% of patients experienced improved or stable vision, despite a 9.4% occurrence of radiation-induced optic neuropathy (RION).* -
  • The findings support proton beam therapy as a safe and effective option for ONSM treatment, though further research is needed to compare its effectiveness against traditional photon radiotherapy.*
View Article and Find Full Text PDF

Optic Nerve Amyloid Deposition Disguised as Optic Nerve Sheath Meningioma.

Ophthalmic Plast Reconstr Surg

November 2024

Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida, U.S.A.

Localized orbital amyloidosis is a rare clinical entity. Periocular and orbital amyloid deposits are mainly located at the lacrimal apparatus, eyelid, conjunctiva, ocular adnexa, extraocular muscles, and levator palpebrae muscle. In this article, the authors report an unusual case of optic nerve amyloid deposition in an 82-year-old African American woman who presented with vertical diplopia.

View Article and Find Full Text PDF

This case study presents the first demonstration of FAPI ligand uptake in a patient with optic nerve sheath meningioma. The patient, a 23-year-old woman who had previously undergone surgery for refractory optic meningioma, was referred to our department for 177Lu-DOTATATE therapy. After 3 cycles of 177Lu-DOTATATE administration, her proptosis significantly decreased.

View Article and Find Full Text PDF

Background: Skull base meningiomas are intricately related to neuro-ophthalmic functions and have been related to direct influences on both the afferent and efferent visual pathways due to close contacts with crucial neurovascular structures. The present article reviews the neuro-ophthalmic presentations of these tumors, necessitating the need for precise anatomic information for the delivery of customized diagnostic and therapeutic approaches.

Methods: A literature review was conducted using PubMed and Scopus, focusing on terms related to skull base meningiomas and their neuro-ophthalmic impacts.

View Article and Find Full Text PDF

Meningiomas are benign tumors of the central nervous system (CNS) that usually result in compression to adjacent structures and rarely cause pathology on their own. Meningiomas can affect the visual pathways originating from perineural or optic nerve sheath meningioma (ONSM), sellar, or clinoid, to the frontal-temporal-parietal-occipital lobes. Frontal meningiomas have an indolent presentation with frequent behavioral changes (i.

View Article and Find Full Text PDF

Objective: To identify factors for tumor relapse and poor outcome in patients with meningiomas in the first two decades of life.

Methods: All patients ≤ 21 years of age who underwent resection of a meningioma at the department of neurosurgery, Medical University of Vienna between 1989 and 2022 were included in this retrospective study. Clinical and radiological data were extracted from the medical records.

View Article and Find Full Text PDF

Pearls & Oy-sters: A Challenging Optic Neuropathy-What Not to Miss in Optic Nerve Sheath Enhancement.

Neurology

June 2024

From the Divisions of Neurology (N.S., A.P.A., L.A.), Neurosurgery (N.S.), and Neuropathology (R.R.), Department of Neurosciences and Mental Health, and Neuroradiology (C.M.), Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Lisbon; and Centro de Estudos Egas Moniz, Faculdade de Medicina (A.P.A., L.A.), Universidade de Lisboa, Lisbon, Portugal.

Optic neuropathies include a wide range of disorders from ischemic, toxic, demyelinating, or inflammatory processes with acute/subacute onset to more gradual compressive or genetic etiologies. Accurate clinical history and multimodality optic nerve imaging including MRI and optical coherence tomography have greatly improved the diagnosis of patients with optic neuropathies. We report a case of a woman with severe monocular visual acuity deficit.

View Article and Find Full Text PDF

Purpose: We aimed to develop and investigate positional reproducibility using a fixation device (Unity Brain tumor Immobilization Device [UBID]) in patients with brain tumor undergoing magnetic resonance (MR)-guided radiation therapy (RT) with a 1.5 Tesla (T) MR-linear accelerator (MR-LINAC) to evaluate its feasibility in clinical practice and report representative cases of patients with central nervous system (CNS) tumor.

Materials And Methods: Quantitative analysis was performed by comparing images obtained by placing only the MR phantom on the couch with those obtained by placing UBID next to the MR phantom.

View Article and Find Full Text PDF

Purpose: The variations in the diameter of the optic nerve (ON) are important clinically in the diagnosis of conditions associated with the ON such as raised intracranial pressure, meningioma, optic neuritis, and Grave's orbitopathy. This study determined the normal diameters of the ON in adult Nigerians seen in a Hospital in Delta State.

Methods: Axial T1-weighted brain magnetic resonance imaging images of 150 patients (75 males and 75 females) aged ≥20 years were retrieved from the hospital's radiological database and retrospectively used to evaluate the diameter of the ON on axial and coronal sections.

View Article and Find Full Text PDF

Objective: Our primary objective is to evaluate the local control of optic nerve sheath meningiomas (ONSMs) treated with ionizing radiation and related visual changes after treatment. Our secondary objective is to describe the clinical characteristics and perform an analysis of the treatment impact on the functional status of this group of patients.

Methods: We present our series of 19 patients treated with ionizing radiation therapy at our radio-neurosurgery unit between 2016 and 2022.

View Article and Find Full Text PDF

Gross-total resection in optic nerve sheath meningiomas: minimally invasive and cosmetic pleasing.

Graefes Arch Clin Exp Ophthalmol

August 2024

National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, 325027, China.

Purpose: The optic nerve sheath meningioma (ONSM) is one of the most challenging tumors in orbital surgery. From the perspective of mental health and patient needs, we analyzed the necessity and importance of the endoscopic transnasal approach (ETA) combined with optic nerve transection (ONT) in gross-total resection (GTR) in ONSM patients with residual vision and aim to broaden the use of ONT for specific people.

Methods: The authors included patients with ONSMs who were treated between 2014 and 2022.

View Article and Find Full Text PDF

Background: Optic nerve sheath meningiomas (ONSM) are rare tumors potentially causing visual deficits. This study aims to report the anatomic and visual outcomes of patients with primary ONSM treated with hypofractionated stereotactic radiotherapy (HF-SRT).

Methods: Data of 36 patients treated with HF-SRT between 2008 and 2019 were retrospectively collected.

View Article and Find Full Text PDF

Optic nerve haemangioblastoma (ONH) is an uncommon, benign, non-meningothelial, mesenchymal tumour of unclear origin. Most are associated with von Hippel-Lindau (VHL) syndrome (71%), and only 40 cases have been reported in the medical literature. Most of the patients develop non-specific visual symptoms, including decreased visual acuity and/or loss of visual fields, exophthalmos, trigeminal neuralgia, and retroorbital pain.

View Article and Find Full Text PDF

An abnormal enlargement of the air-filled paranasal sinuses is referred to as pneumosinus dilatans. Typically discovered incidentally through radiological examinations, it infrequently manifests as cosmetic, neurological, ocular, or rhinological pathologies. Thorough evaluation for associated conditions is essential in patients with pneumosinus dilatans, including meningiomas of the anterior skull base or the optic nerve sheath.

View Article and Find Full Text PDF

[Orbital tumors].

Radiologie (Heidelb)

March 2024

Aretaieion Universitätsklinkum für Radiologie, Universität von Athen, Athen, Griechenland.

Article Synopsis
  • Orbital tumors are various diseases affecting the eye area, and early detection is crucial for effective treatment, especially for malignant cases.
  • Neuroradiological imaging, particularly MRI, is key for diagnosing these tumors, with adults often experiencing lymphoproliferative diseases and children more frequently dealing with dermoid cysts and optic gliomas.
  • Specific tumors like optic glioma, which is a type of pilocytic astrocytoma, and retinoblastoma, an aggressive childhood tumor, have distinct characteristics that help doctors narrow down their diagnoses based on patient age, tumor location, and imaging results.
View Article and Find Full Text PDF

Optic Nerve Sheath Meningiomas: A National Surveillance, Epidemiology, and End Results (SEER) Database Analysis.

J Neuroophthalmol

September 2024

Dean McGee Eye Institute (ZSH, KMR), Oklahoma City, Oklahoma; University of Medicine and Health Sciences (ZSH), Basseterre, Saint Kitts and Nevis; Department of Ophthalmology (AL), Baylor College of Medicine, Houston, Texas; Center for Space Medicine (AGL), Baylor College of Medicine, Houston, Texas; The Houston Methodist Research Institute (AGL), Houston Methodist Hospital, Houston, Texas; Departments of Ophthalmology, Neurology, and Neurosurgery (AGL), Weill Cornell Medicine, New York, New York; Department of Ophthalmology (AGL), University of Texas Medical Branch, Galveston, Texas; University of Texas MD Anderson Cancer Center (AGL), Houston, Texas; Texas A&M College of Medicine (AGL), Bryan, Texas; and Department of Ophthalmology (AGL), The University of Iowa Hospitals and Clinics, Iowa City, Iowa.

Background: Optic nerve sheath meningioma (ONSM) is a rare optic nerve cancer with considerable morbidity. This national analysis validates previously known ONSM concepts while providing insight into novel risk factors.

Methods: The Surveillance, Epidemiology, and End Results (SEER) Program was queried from 2000 to 2019 for all histologic subtypes of meningioma primary to the optic nerve.

View Article and Find Full Text PDF

Rapidly progressive optic neuropathy due to optic nerve sheath meningioma following hormonal fertility treatment.

Can J Ophthalmol

December 2023

Blanton Eye Institute, Houston Methodist Hospital, Houston, TX; Weill Cornell Medicine, New York, NY; University of Texas Medical Branch, Galveston, TX; University of Texas MD Anderson Cancer Center, Houston, TX; Texas A&M College of Medicine, Bryan, TX; University of Iowa Hospitals and Clinics, Iowa City, IA. Electronic address:

View Article and Find Full Text PDF

Visual Outcomes Following Surgical Debulking in Exophytic Optic Nerve Sheath Meningiomas.

Ophthalmic Plast Reconstr Surg

March 2024

Division of Orbital and Ophthalmic Plastic Surgery, Jules Stein Eye Institute, University of California, Los Angeles, California, U.S.A.

Purpose: To report a case of a globular primary optic nerve sheath meningioma managed surgically with improvement in vision and review the literature for outcomes of purely intraorbital exophytic-globular primary optic nerve sheath meningiomas managed surgically.

Methods: A literature review was conducted using Google Scholar and PubMed with the search terms "primary optic nerve sheath meningioma," "surgery," "exophytic," and "globular." Articles were included if they were available in English.

View Article and Find Full Text PDF

Optic Nerve Sheath Meningiomas: Solving Diagnostic Challenges with Ga-DOTATOC PET/CT.

Diagnostics (Basel)

July 2023

Neurosurgery Department, INSERM, MMG, APHM, Timone Hospital, Aix-Marseille University, 13005 Marseille, France.

Ga-DOTATOC PET could be a noninvasive, highly sensitive, and specific technique for the challenging diagnosis of optic nerve sheath meningioma (ONSM). Our objective was to report the use and results of Ga-DOTATOC PET in suspected ONSM. Twelve subjects who underwent Ga-DOTATOC PET for suspected ONSM in our department were retrospectively included.

View Article and Find Full Text PDF

Does Adjuvant Gamma Knife Stereotactic Radiosurgery Have a Role in Treating Optic Nerve Sheath Meningiomas?

J Neuroophthalmol

June 2024

Departments of Neurological Surgery (ZW, HD, AN, LDL) and Neurology (SS), University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania; and University of Pittsburgh School of Medicine (ZW, ST), Pittsburgh, Pennsylvania.

Background: Meningiomas arising from or adjacent to the optic nerve sheath meningioma (ONSM) are management challenges because of their risk of visual loss. Stereotactic radiosurgery (SRS) is a minimally invasive modality that can be added as adjuvant treatment for patients whose tumor has progressed or recurred after initial resection.

Methods: The authors retrospectively reviewed 2,030 meningioma patients who underwent SRS between 1987 and 2022.

View Article and Find Full Text PDF